Abstract
Polygenic scores (PGS) offer moderate to high prediction accuracy for complex traits, but most are developed in European ancestry cohorts, reducing their performance in populations of other ancestries. This study aimed to improve standing height prediction, a heritable and ancestry-influenced trait, in an admixed Latino cohort (HCHS/SOL) by modeling ancestry using principal components (PCs) alongside PGS. SNPs were selected from a large European ancestry GWAS using various p-value thresholds, and weights were trained using traditional and penalized regression in the UK Biobank (UKB). PGS with PCs were trained separately in HCHS/SOL and UKB. Compared to PGS alone, modeling PGS with PCs substantially improved height prediction in HCHS/SOL (R² increase of ∼0.1), while mild improvements were observed in UKB (R² increase of ∼0.01). These results underscore the importance of incorporating genetic ancestry into predictive models for admixed populations, particularly when the trait exhibits ancestry-specific associations.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors thank the staff and participants of HCHS/SOL for their important contributions. Investigators website‐ http://www.cscc.unc.edu/hchs/. The Hispanic Community Health Study/Study of Latinos is a collaborative study supported by contracts from the National Heart, Lung, and Blood Institute (NHLBI) to the University of North Carolina (HHSN268201300001I / N01‐HC‐65233), University of Miami (HHSN268201300004I / N01‐HC‐65234), Albert Einstein College of Medicine (HHSN268201300002I / N01‐HC‐65235), University of Illinois at Chicago (HHSN268201300003I / N01‐HC‐65236 Northwestern Univ), and San Diego State University (HHSN268201300005I / N01‐HC‐65237). The following Institutes/Centers/Offices have contributed to the HCHS/SOL through a transfer of funds to the NHLBI: National Institute on Minority Health and Health Disparities, National Institute on Deafness and Other Communication Disorders, National Institute of Dental and Craniofacial Research, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Neurological Disorders and Stroke, NIH Institution‐Office of Dietary Supplements. The views expressed in this manuscript are those of the authors and do not necessarily represent the views of the National Heart, Lung, and Blood Institute; the National Institutes of Health; or the U.S. Department of Health and Human Services.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of Hispanic Community Health Study/Study of Latinos (HCHS/SOL) gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.